PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
10-May-2022 ANI Pharmaceuticals Reports First Quarter 2022 Results; Provides Purified Cortrophin® Gel Net Revenue Guidance and Full-Year 2022 Total Company Net Revenue Guidance of $295 Million to $315 Million Businesswire
10-May-2022 Pfizer to Acquire Biohaven Pharmaceuticals Businesswire
10-May-2022 Stevanato Group Reports First Quarter 2022 Financial Results Businesswire
10-May-2022 Aurinia Reports First Quarter 2022 Financial and Operational Results Businesswire
10-May-2022 Global Environmental Monitoring Market to 2028 - Featuring 3M, Aeroqual and Agilent Technologies Among Others - ResearchAndMarkets.com Businesswire
10-May-2022 Global AI-based Drug Discovery Market (2022 to 2035) - by Drug Discovery Steps, Therapeutic Area and Key Geographies - ResearchAndMarkets.com Businesswire
10-May-2022 Global Carbapenem-Based Antibiotics Market Forecast Report to 2028: Rising Prevalence of Gram-Negative Bacterial Infections and Increasing Production of Generic Drugs - ResearchAndMarkets.com Businesswire
10-May-2022 Inventprise Inaugurates Manufacturing Facility for High-Capacity Supply of Pneumococcal Conjugate Vaccines Businesswire
10-May-2022 New programme celebrates ChargePoint Technology's role in COVID-19 vaccine rollout ChargePoint Technology
10-May-2022 First Trust Global Funds PLC UK Regulatory Announcement: Net Asset Value(s) Businesswire
10-May-2022 Recuro Health Awarded as Technology Pioneer by World Economic Forum Businesswire
10-May-2022 EMQ Awarded as Technology Pioneer by World Economic Forum Businesswire
10-May-2022 FSD Pharma Closes CAD$16.4 Million Sale of Non-Core Assets Businesswire
10-May-2022 Sygnature Discovery to Deploy Iktos’s AI for Drug Design Software Makya™ Businesswire
10-May-2022 TheraVet Signs an Important Distribution Agreement With the Orthopaedics & Surgical Instrumentation Distributor, Veterinary Instrumentation Businesswire
10-May-2022 Sensorion Provides Preliminary Documents for the Combined Shareholders’ General Meeting of May 31, 2022 Businesswire
10-May-2022 InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization Newswire
10-May-2022 Monrol Is Partnering With Telix Pharmaceuticals, Supplying Lutetium nca Lu 177 for the Manufacturing of Clinical Doses for the Phase II STARLITE 2 Study At MSK and Manufacturing Clinical Doses for Telix’s Phase III ZIRCON Trial Businesswire
10-May-2022 Blue Note Therapeutics and Bixink Enter Licensing Agreement for attune™ and DreAMLand™, Prescription Digital Therapeutics for Mental Well-Being in Cancer Patients Newswire
09-May-2022 Voluntary Improvement Program (VIP) Becomes the First Case for Quality Program Recognized by the FDA Businesswire